AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 4062052
Drug: 4% lidocaine
RxNorm normalized name: Lidocaine 344 mg TOPICAL PATCH [Pain Relief 4% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% lidocaine plus decongestant
Trial: 4062052
Drug: Placebo (decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (decongestant plus saline)
Trial: 30466597
Drug: Nitrate re-supply
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate re-supply treatment
Trial: 30466597
Drug: Nitrate starvation
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate starvation treatment
Trial: 30466597
Drug: Nitrate treatments
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate treatments (combined starvation and re-supply)
Trial: 20202235
Drug: Intramuscular diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diclofenac 75 mg at the end of the operation followed by 75 mg for 24 hours (150 mg/24 h)
Trial: 20202235
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol 1g/100 mL twice daily as postoperative analgesia
Trial: 18018837
Drug: Halothane 1
RxNorm normalized name: halothane 1000 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane 1 ml, Isoflurane 1.5 ml, Sevoflurane 2.7 ml (experiment 1)
Trial: 18018837
Drug: Halothane 2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane 2, 4, and 6 ml (experiment 2)
Trial: 18018837
Drug: Sevoflurane 5
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane 5 ml (experiment 3)
Trial: 2054701
Drug: Midazolam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.3 to 0.5 mg/kg) combined with atropine sulfate (0.015 mg/kg)
Trial: 2054701
Drug: Placebo (injectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (injectable water) combined with atropine sulfate (0.015 mg/kg)
Trial: 6356966
Drug: Terbutaline inhalations
RxNorm normalized name: terbutaline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline inhalations (31 + 31 + 63 + 125 + 250 micrograms) from a pressurized aerosol with a 750 ml spacer
Trial: 28137609
Drug: Dietary nitrate
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary nitrate load (300 mg) by highly concentrated beetroot juice (BJ)
Trial: 21397780
Drug: 400-mg rufinamide
RxNorm normalized name: rufinamide 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-mg rufinamide tablet (reference)
Trial: 21397780
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of rufinamide suspension (40 mg/mL) at 1800 rpm
Trial: 21397780
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of rufinamide suspension (40 mg/mL) at 2100 rpm
Trial: 21397780
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of rufinamide suspension (40 mg/mL) at 3000 rpm
Trial: 18444817
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of cefuroxime 10‐30 min before inflation of the tourniquet and placebo 10 min before release of the tourniquet (standard arm)
Trial: 18444817
Drug: Placebo 10‐30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 10‐30 min before inflation of the tourniquet and 1.5 g of cefuroxime 10 min before release of the tourniquet (experimental arm)
Trial: 11097670
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with dexamethasone 0.13 mg/mL
Trial: 11097670
Drug: Ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.5% with dexamethasone 0.13 mg/mL
Trial: 9315064
Drug: Primary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary therapy with tamoxifen alone (n=160)
Trial: 8336864
Drug: Zoladex (goserelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoladex (goserelin acetate), 3.6 mg every 28 days by subcutaneous injection
Trial: 8336864
Drug: Danazol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol, 400 mg orally twice daily for 24 weeks
Trial: 3276422
Drug: Adjunctive interfascicular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive interfascicular neurolysis
Trial: 28057058
Drug: Lian-Ju-Gan-Mao capsules
RxNorm normalized name: Gan Cao Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lian-Ju-Gan-Mao capsules (LJGMC) high-dose group
Trial: 28057058
Drug: Lian-Ju-Gan-Mao capsules
RxNorm normalized name: Gan Cao Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lian-Ju-Gan-Mao capsules (LJGMC) medium-dose group
Trial: 28057058
Drug: Lian-Ju-Gan-Mao capsules
RxNorm normalized name: Gan Cao Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lian-Ju-Gan-Mao capsules (LJGMC) low-dose group
Trial: 12575402
Drug: Shenkang injection
RxNorm normalized name: CAMPHOR (SYNTHETIC) 4.28 mg in 100 mg / MENTHOL 2.84 mg in 100 mg / METHYL SALICYLATE 1.4 mg in 100 mg TRANSDERMAL PLASTER [Shennong Analgesic Plaster]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenkang injection (SKI)
Trial: 7984593
Drug: Adjuvant endovascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant endovascular irradiation of blood with He‐Ne laser (8-10 daily sessions lasting 30 minutes)
Trial: 18603505
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 micrograms every 4 hours for a maximum of four doses)
Trial: 15729173
Drug: Supplemental arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Supplemental arginine and canola oil (omega-3 and omega-9 fatty acids) twice daily
Trial: 11046211
Drug: HES200 (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES200 (15 ml/kg)
Trial: 11046211
Drug: HES70 (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES70 (15 ml/kg)
Trial: 9075745
Drug: Preoperative multimodality
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative multimodality therapy (Group 1) including seven cycles of 5-fluorouracil (FU)/leucovorin (LV) chemotherapy and radiation therapy (5,040 cGy) before surgery.
Trial: 9075745
Drug: Postoperative multimodality
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative multimodality therapy (Group 2) including the same chemotherapy and radiation therapy after surgery.
Trial: 9075745
Drug: Preoperative multimodality
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative multimodality therapy (Group 1).
Trial: 9075745
Drug: Postoperative multimodality
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative multimodality therapy (Group 2).
Trial: 8422745
Drug: Fenoterol metered
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol metered dose inhaler (0.4 mg)
Trial: 8422745
Drug: Fenoterol dry
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol dry powder capsules (0.4 mg)
Trial: 8422745
Drug: Colforsin dry
RxNorm normalized name: Colforsin
DrugBank: Colforsin (DB02587)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colforsin dry powder capsules (10.0 mg)
Trial: 23470806
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus cilostazol (cilo)
Trial: 23470806
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (non-cilo group)
Trial: 19111610
Drug: Antioxidant (AO)
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant (AO) supplementation (200 IU of vitamin E and 500 mg ascorbic acid)
Trial: 16641947
Drug: Neurocognitive tests
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurocognitive tests administered (11 tests resulting in 24 individual scores)
Trial: 11399983
Drug: Amprenavir (APV)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (APV) 450 mg with Ritonavir (RTV) 300 mg
Trial: 11399983
Drug: Amprenavir (APV)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (APV) 450 mg with Ritonavir (RTV) 100 mg
Trial: 11399983
Drug: Amprenavir (APV)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (APV) 900 mg with Ritonavir (RTV) 100 mg
Trial: 11399983
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) co-administration with APV
Trial: 11399983
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) 300 mg
Trial: 11399983
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) 100 mg
Trial: 9757514
Drug: Hop-valerian preparation
RxNorm normalized name: HOPS
DrugBank: Hops (DB10687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hop-valerian preparation
Trial: 9757514
Drug: Benzodiazepine preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepine preparation
Trial: 7914050
Drug: Haloperidol (2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (2, 4 and 6 mg)
Trial: 7914050
Drug: Remoxipride (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remoxipride (100 and 150 mg)
Trial: 16989189
Drug: 633-nm and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 633-nm and 830-nm LED treatments
Trial: 15259281
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day of tricalcium phosphate (TCP)
Trial: 15259281
Drug: 500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/day of ossein‐hydroxyapatite (OHC)
Trial: 8570762
Drug: Brofaromine (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine (selective and reversible inhibitor of monoamine oxidase type A)
Trial: 8570762
Drug: Imipramine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (standard tricyclic compound)
Trial: 105442
Drug: Chemotherapeutic agents
RxNorm normalized name: Other chemotherapeutics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapeutic agents
Trial: 29354921
Drug: Scraping therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scraping therapy (4 sessions over 4 weeks)
Trial: 29354921
Drug: Scraping therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scraping therapy (lung qi deficiency and cold group)
Trial: 29354921
Drug: Cetirizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (10 mg, once a day for 4 weeks)
Trial: 23598607
Drug: CPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP treatment for 6 months
Trial: 25601933
Drug: CPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP treatment (per-protocol analysis)
Trial: 20711439
Drug: Superficial heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Superficial heat therapy
Trial: 17394940
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 45 mg orally three times daily
Trial: 16287453
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg daily for 2 weeks
Trial: 28333362
Drug: Budesonide multimatrix
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide multimatrix 9 mg
Trial: 26600646
Drug: Structured Oral
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured Oral Examination (SOE)
Trial: 23924446
Drug: Immediate intravesical
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate intravesical instillation of Pirarubicin (THP) 30 mg/50 ml within 24 hours post TUR, followed by regular instillations once a week for 8 weeks, then once a month for 1 year.
Trial: 23924446
Drug: Regular intravesical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intravesical therapy only.
Trial: 23924446
Drug: Regular intravesical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intravesical therapy only for low and intermediate-risk patients.
Trial: 23924446
Drug: Regular intravesical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intravesical therapy only for high-risk patients.
Trial: 19589565
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg followed by 200 mg every 12 hours for 10 days
Trial: 11385230
Drug: Griseofulvin 600
RxNorm normalized name: Griseofulvin
DrugBank: Griseofulvin (DB00400)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Griseofulvin 600 mg twice daily for 12 months
Trial: 11385230
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg daily for 4 months
Trial: 11385230
Drug: Itraconazole pulse
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole pulse therapy (200 mg twice daily for 1 week with 3 weeks off between pulses)
Trial: 1392793
Drug: Terbinafine 250
RxNorm normalized name: terbinafine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 250 mg daily for 12 weeks
Trial: 11385230
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg daily for 12 weeks
Trial: 1443356
Drug: Cefotaxime 1
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 1 g intramuscular (i.m.) 1 hour preoperatively and a second dose 1 hour before catheter removal (Study 1)
Trial: 1443356
Drug: Cefotaxime 1
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 1 g i.m. 1 hour preoperatively (Study 2)
Trial: 1443356
Drug: Cefotaxime 1
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 1 g i.m. 1 hour before catheter removal (Study 2)
Trial: 15724865
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no magnesium therapy)
Trial: 6399346
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium therapy (subgroup without heart failure)
Trial: 29532734
Drug: sirukumab 50
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirukumab 50 mg q4w
Trial: 29532734
Drug: sirukumab 100
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirukumab 100 mg q2w
Trial: 22773291
Drug: Physiotherapy group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy group (PG) - 15 minutes of daily passive movements with gentle joint compression 5 days a week
Trial: 19965548
Drug: Cinacalcet plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet plus low-dose calcitriol analogs (Cinacalcet-D)
Trial: 18664988
Drug: Penicillin/erythromycin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin/erythromycin therapy at school for positive throat cultures
Trial: 15882245
Drug: Moxifloxacin, amoxicillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin, amoxicillin, and esomeprazole (Group MAE)
Trial: 15882245
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy with clarithromycin, amoxicillin, and esomeprazole (Group CAE)
Trial: 15882245
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy with tinidazole (Group CTE)
Trial: 12963604
Drug: Topical 0.3%
RxNorm normalized name: triclosan topical 0.3% topical bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.3% ciprofloxacin solution or ointment
Trial: 15321076
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg subarachnoid diamorphine
Trial: 15321076
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg epidural diamorphine
Trial: 8675360
Drug: Random urine
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random urine urea excretion indices
Trial: 3893776
Drug: Chloroquine single
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine single dose of 10 mg/kg
Trial: 3893776
Drug: Chloroquine full
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine full dose of 25 mg/kg
Trial: 29777297
Drug: High verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High verapamil administration (18%)
Trial: 27119576
Drug: LCZ696 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 (400 mg, single dose) with omeprazole (40 mg q.d.)
Trial: 27119576
Drug: LCZ696 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 (400 mg, single dose) with metformin (1000 mg q.d.)
Trial: 27119576
Drug: LCZ696 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 (400 mg, single dose) with levonorgestrel-ethinyl estradiol (150/30 μg single dose)
Trial: 18094224
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg alone
Trial: 18094224
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg followed by aspirin 325 mg 2 hours later
Trial: 18094224
Drug: Aspirin with
RxNorm normalized name: Bayer Aspirin with Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin with NSAID (ibuprofen or naproxen)
Trial: 1596968
Drug: 0.5 ml.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml.kg‐1 bupivacaine 0.125% with 1:200,000 epinephrine
Trial: 1596968
Drug: 1 ml.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml.kg‐1 bupivacaine 0.125% with 1:200,000 epinephrine
Trial: 31248843
Drug: Triple-drug group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug group (cyclosporine, mycophenolate mofetil, and sirolimus)
Trial: 31248843
Drug: Triple-drug group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug group
Trial: 29102441
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - 2 injections
Trial: 24996030
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DSP and SG with ALB
Trial: 20473067
Drug: Antidepressant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant therapy alone (Control)
Trial: 15231010
Drug: Oral daily
RxNorm normalized name: Summer's Eve Sheer Floral Daily Cloths
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral daily ibandronate (2.5 mg)
Trial: 11874442
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sibutramine bid
Trial: 11874442
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg orlistat tid
Trial: 11874442
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg metformin bid
Trial: 10440605
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg or 10 mg)
Trial: 7560246
Drug: MS-CRS (controlled-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS-CRS (controlled-release suppository)
Trial: 6938013
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg diethylstilbestrol (DES) daily by mouth
Trial: 31134731
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT-T) delivered by trainee psychologists
Trial: 28880609
Drug: Discontinued use
RxNorm normalized name: Entex HC Discontinued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued use of antipsychotics
Trial: 28880609
Drug: Continued use
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued use of antipsychotics